In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|17|1|54-68

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.17, Iss.1, 2018-04, pp. : 54-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease

By Recanatini Maurizio   Cavalli Andrea  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1853-1865

Informa Healthcare

Access to resources Recommend Favorite

QSAR Applications During Last Decade on Inhibitors of Acetylcholinesterase in Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-09 ,pp. : 936-946

Bentham Science Publishers

Access to resources Recommend Favorite

Fighting Against Alzheimer#39;s Disease: Synthesis of New Pyrazoline and Benzothiazole Derivatives as New Acetylcholinesterase and MAO Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 4, 2018-03 ,pp. : 414-427

Bentham Science Publishers

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer’s disease: do we need new inhibitors?

By Small David H  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 817-825

Informa Healthcare

Access to resources Recommend Favorite